The role and challenges of biomarkers in spontaneous preterm birth and preeclampsia

Fertility and Sterility

Volumn 99, Issue 4, 2013, Pages 1117-1123

  Bastek, Jamie A ^a   Elovitz, Michal A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarkers; preeclampsia; spontaneous preterm birth

Indexed keywords

ACTIVIN A; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; DNA; ENDOGLIN; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBIN A; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LIPID PEROXIDASE; MATRIX METALLOPROTEINASE; PENTRAXIN 3; PLACENTAL GROWTH FACTOR; PROSTAGLANDIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

AMNION; AMNION FLUID; CHORION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; NATURAL KILLER CELL; PREDICTIVE VALUE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RISK ASSESSMENT; STANDARDIZATION;

ABORTION, SPONTANEOUS; BIOLOGICAL MARKERS; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RISK FACTORS;

EID: 84876406948     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.01.104     Document Type: Conference Paper

References (101)

1. ACOG practice bulletin no. 127: Management of preterm labor Obstet Gynecol 119 2012 1308 1317
2. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002 Obstet Gynecol 99 2002 159 167
3. M.J. Khoury, L. Bertram, P. Boffetta, A.S. Butterworth, S.J. Chanock, and S.M. Dolan Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases Am J Epidemiol 170 2009 269 279
4. I.A. Buhimschi Using SELDI-TOF mass spectrometry on amniotic fluid and for clinical proteomics and theranostics in disorders of pregnancy Methods Mol Biol 818 2012 171 197
5. L.F. Goncalves, T. Chaiworapongsa, and R. Romero Intrauterine infection and prematurity Ment Retard Dev Disabil Res Rev 8 2002 3 13
6. R. Romero, C.M. Salafia, A.P. Athanassiadis, S. Hanaoka, M. Mazor, and W. Sepulveda The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology Am J Obstet Gynecol 166 1992 1382 1388
7. R. Romero, D.T. Brody, E. Oyarzun, M. Mazor, Y.K. Wu, and J.C. Hobbins Infection and labor. III. Interleukin-1: a signal for the onset of parturition Am J Obstet Gynecol 160 1989 1117 1123
8. R. Romero, Y.K. Wu, D.T. Brody, E. Oyarzun, G.W. Duff, and S.K. Durum Human decidua: a source of interleukin-1 Obstet Gynecol 73 1989 31 34
9. R. Romero, S. Durum, C.A. Dinarello, E. Oyarzun, J.C. Hobbins, and M.D. Mitchell Interleukin-1 stimulates prostaglandin biosynthesis by human amnion Prostaglandins 37 1989 13 22
10. D.W. Sadowsky, M.J. Novy, S.S. Witkin, and M.G. Gravett Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys Am J Obstet Gynecol 188 2003 252 263
11. R. Romero, M. Mazor, and B. Tartakovsky Systemic administration of interleukin-1 induces preterm parturition in mice Am J Obstet Gynecol 165 1991 969 971
12. W.W. Andrews, J.C. Hauth, R.L. Goldenberg, R. Gomez, R. Romero, and G.H. Cassell Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery Am J Obstet Gynecol 173 1995 606 612
13. S.M. Cox, M.R. King, M.L. Casey, and P.C. MacDonald Interleukin-1 beta, -1 alpha, and -6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor J Clin Endocrinol Metab 77 1993 805 815
14. R. Gomez, R. Romero, M. Galasso, E. Behnke, A. Insunza, and D.B. Cotton The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term Am J Reprod Immunol 32 1994 200 210
15. S.L. Hillier, S.S. Witkin, M.A. Krohn, D.H. Watts, N.B. Kiviat, and D.A. Eschenbach The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection Obstet Gynecol 81 1993 941 948
16. J. Messer, D. Eyer, L. Donato, H. Gallati, J. Matis, and U. Simeoni Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection J Pediatr 129 1996 574 580
17. R. Romero, C. Avila, U. Santhanam, and P.B. Sehgal Amniotic fluid interleukin 6 in preterm labor. Association with infection J Clin Invest 85 1990 1392 1400
18. P.H. Cherouny, G.A. Pankuch, R. Romero, J.J. Botti, D.C. Kuhn, and L.M. Demers Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants Am J Obstet Gynecol 169 1993 1299 1303
19. S. Saito, T. Kasahara, Y. Kato, Y. Ishihara, and M. Ichijo Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition Cytokine 5 1993 81 88
20. F. Ghezzi, R. Gomez, R. Romero, B.H. Yoon, S.S. Edwin, and C. David Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia Eur J Obstet Gynecol Reprod Biol 78 1998 5 10
21. R. Romero, M. Ceska, C. Avila, M. Mazor, E. Behnke, and I. Lindley Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition Am J Obstet Gynecol 165 1991 813 820
22. B.H. Yoon, R. Romero, J.K. Jun, K.H. Park, J.D. Park, and F. Ghezzi Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia Am J Obstet Gynecol 177 1997 825 830
23. C. Gonzalez, F. Cava, A. Ayllon, P. Guevara, J.A. Navajo, and J.M. Gonzalez-Buitrago Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals Clin Chem Lab Med 39 2001 836 841
24. R. Romero, K.R. Manogue, M.D. Mitchell, Y.K. Wu, E. Oyarzun, and J.C. Hobbins Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor Am J Obstet Gynecol 161 1989 336 341
25. R. Romero, M. Mazor, Y.K. Wu, M. Sirtori, E. Oyarzun, and M.D. Mitchell Infection in the pathogenesis of preterm labor Semin Perinatol 12 1988 262 279
26. M.L. Casey, S.M. Cox, B. Beutler, L. Milewich, and P.C. MacDonald Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor J Clin Invest 83 1989 430 436
27. R. Romero, M. Mazor, K. Manogue, E. Oyarzun, and A. Cerami Human decidua: a source of cachectin-tumor necrosis factor Eur J Obstet Gynecol Reprod Biol 41 1991 123 127
28. S.J. Fortunato, R. Menon, and S.J. Lombardi Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways Am J Obstet Gynecol 187 2002 1159 1162
29. K. Watari, S. Nakao, A. Fotovati, Y. Basaki, F. Hosoi, and B. Bereczky Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation Biochem Biophys Res Commun 377 2008 826 831
30. E. Maymon, R. Romero, P. Pacora, M.T. Gervasi, R. Gomez, and S.S. Edwin Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection Am J Obstet Gynecol 183 2000 887 894
31. R. Romero, T. Chaiworapongsa, J. Espinoza, R. Gomez, B.H. Yoon, and S. Edwin Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes Am J Obstet Gynecol 187 2002 1125 1130
32. K. Chwalisz, M. Benson, P. Scholz, J. Daum, H.M. Beier, and C. Hegele-Hartung Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs Hum Reprod 9 1994 2173 2181
33. S. Kajikawa, N. Kaga, Y. Futamura, C. Kakinuma, and Y. Shibutani Lipoteichoic acid induces preterm delivery in mice J Pharmacol Toxicol Methods 39 1998 147 154
34. E. Hirsch, Y. Filipovich, and M. Mahendroo Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model Am J Obstet Gynecol 194 2006 1334 1340
35. L.L. Klein, and R.S. Gibbs Infection and preterm birth Obstet Gynecol Clin North Am 32 2005 397 410
36. J.A. Keelan, M. Blumenstein, R.J. Helliwell, T.A. Sato, K.W. Marvin, and M.D. Mitchell Cytokines, prostaglandins and parturition - a review Placenta 24 Suppl A 2003 S33 S46
37. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Epidemiology and causes of preterm birth Lancet 371 2008 75 84
38. R.L. Goldenberg, J.C. Hauth, and W.W. Andrews Intrauterine infection and preterm delivery N Engl J Med 342 2000 1500 1507
39. R. Romero, J. Espinoza, J.P. Kusanovic, F. Gotsch, S. Hassan, and O. Erez The preterm parturition syndrome Br J Obstet Gynecol 113 Suppl 3 2006 17 42
40. S.Q. Wei, W. Fraser, and Z.C. Luo Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review Obstet Gynecol 116 2010 393 401
41. A. Conde-Agudelo, A.T. Papageorghiou, S.H. Kennedy, and J. Villar Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis Br J Obstet Gynecol 118 2011 1042 1054
42. J.M. O'Brien, G.H. Peeler, D.W. Pitts, M.M. Salama, B.M. Sibai, and B.M. Mercer Cervicovaginal prolactin: a marker for spontaneous preterm delivery Am J Obstet Gynecol 171 1994 1107 1111
43. B.H. Yoon, S.Y. Oh, R. Romero, S.S. Shim, S.Y. Han, and J.S. Park An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery Am J Obstet Gynecol 185 2001 1162 1167
44. R. Menon, M.R. Torloni, C. Voltolini, M. Torricelli, M. Merialdi, and A.P. Betran Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades Reprod Sci 18 2011 1046 1070
45. C.J. Lockwood, A.E. Senyei, M.R. Dische, D. Casal, K.D. Shah, and S.N. Thung Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery N Engl J Med 325 1991 669 674
46. R.F. Feinberg, H.J. Kliman, and C.J. Lockwood Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol 138 1991 537 543
47. R.L. Goldenberg, E. Thom, A.H. Moawad, F. Johnson, J. Roberts, and S.N. Caritis The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network Obstet Gynecol 87 1996 656 660
48. G.C. Lu, R.L. Goldenberg, S.P. Cliver, U.S. Kreaden, and W.W. Andrews Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women Obstet Gynecol 97 2001 225 228
49. W.A. Grobman, E.E. Welshman, and E.A. Calhoun Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial Am J Obstet Gynecol 191 2004 235 240
50. N. Hanna, and D. Kiefer A translational view of biomarkers in preterm labor Am J Reprod Immunol 67 2012 268 272
51. C.S. Buhimschi, V. Bhandari, B.D. Hamar, M.O. Bahtiyar, G. Zhao, and A.K. Sfakianaki Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis PLoS Med 4 2007 e18
52. I.A. Buhimschi, R. Christner, and C.S. Buhimschi Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation Br J Obstet Gynecol 112 2005 173 181
53. D. Raymond, and E. Peterson A critical review of early-onset and late-onset preeclampsia Obstet Gynecol Surv 66 2011 497 506
54. M. Torricelli, C. Voltolini, M. De Bonis, F.L. Vellucci, N. Conti, and F.M. Severi The identification of high risk pregnancy: a new challenge in obstetrics J Matern Fetal Neonatal Med 25 Suppl 1 2012 2 5
55. V. Eremina, M. Sood, J. Haigh, A. Nagy, G. Lajoie, and N. Ferrara Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases J Clin Invest 111 2003 707 716
56. V. Eremina, J.A. Jefferson, J. Kowalewska, H. Hochster, M. Haas, and J. Weisstuch VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136
57. T.V. Patel, J.A. Morgan, G.D. Demetri, S. George, R.G. Maki, and M. Quigley A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib J Natl Cancer Inst 100 2008 282 284
58. S. Verlohren, H. Stepan, and R. Dechend Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia Clin Sci (Lond) 122 2012 43 52
59. S. Grill, C. Rusterholz, R. Zanetti-Dallenbach, S. Tercanli, W. Holzgreve, and S. Hahn Potential markers of preeclampsia - a review Reprod Biol Endocrinol 7 2009 70
60. D.M. Carty, C. Delles, and A.F. Dominiczak Novel biomarkers for predicting preeclampsia Trends Cardiovasc Med 18 2008 186 194
61. A.M. Fayyad, and K.F. Harrington Prediction and prevention of preeclampsia and IUGR Early Hum Dev 81 2005 865 876
62. N.G. Than, R. Romero, R. Hillermann, V. Cozzi, G. Nie, and B. Huppertz Prediction of preeclampsia - a workshop report Placenta 29 Suppl A 2008 S83 S85
63. S. Costa Fda, P. Murthi, R. Keogh, and N. Woodrow Early screening for preeclampsia Rev Bras Ginecol Obstet 33 2011 367 375
64. F.J. Schneuer, N. Nassar, A.Z. Khambalia, V. Tasevski, A.W. Ashton, and J.M. Morris First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: In-house study and systematic review Placenta 33 2012 735 740
65. S. Hahn, and B.G. Zimmermann Cell-free DNA in maternal plasma: has the size-distribution puzzle been solved? Clin Chem 56 2010 1210 1211
66. H. Hagmann, R. Thadhani, T. Benzing, S.A. Karumanchi, and H. Stepan The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia Clin Chem 58 2012 837 845
67. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
68. K. Koga, Y. Osuga, O. Yoshino, Y. Hirota, X. Ruimeng, and T. Hirata Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2003 2348 2351
69. V. Tsatsaris, F. Goffin, C. Munaut, J.F. Brichant, M.R. Pignon, and A. Noel Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 2003 5555 5563
70. S. Ahmad, and A. Ahmed Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia Circ Res 95 2004 884 891
71. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
72. A. Hertig, N. Berkane, G. Lefevre, K. Toumi, H.P. Marti, and J. Capeau Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia Clin Chem 50 2004 1702 1703
73. T. Chaiworapongsa, R. Romero, Y.M. Kim, G.J. Kim, M.R. Kim, and J. Espinoza Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia J Matern Fetal Neonatal Med 17 2005 3 18
74. G.C. McKeeman, J.E. Ardill, C.M. Caldwell, A.J. Hunter, and N. McClure Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop Am J Obstet Gynecol 191 2004 1240 1246
75. J. Woolcock, A. Hennessy, B. Xu, C. Thornton, J. Tooher, and A. Makris Soluble Flt-1 as a diagnostic marker of pre-eclampsia Aust N Z J Obstet Gynaecol 48 2008 64 70
76. E. Shibata, A. Rajakumar, R.W. Powers, R.W. Larkin, C. Gilmour, and L.M. Bodnar Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor J Clin Endocrinol Metab 90 2005 4895 4903
77. M. Noori, A.E. Donald, A. Angelakopoulou, A.D. Hingorani, and D.J. Williams Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension Circulation 122 2010 478 487
78. R.J. Levine, C. Lam, C. Qian, K.F. Yu, S.E. Maynard, and B.P. Sachs Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
79. A.K. Wikstrom, A. Larsson, U.J. Eriksson, P. Nash, S. Norden-Lindeberg, and M. Olovsson Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia Obstet Gynecol 109 2007 1368 1374
80. M. Jacobs, N. Nassar, C.L. Roberts, R. Hadfield, J.M. Morris, and A.W. Ashton Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review Reprod Biol Endocrinol 9 2011 77
81. S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, and Y.M. Kim Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
82. A. Wang, S. Rana, and S.A. Karumanchi Preeclampsia: the role of angiogenic factors in its pathogenesis Physiology (Bethesda) 24 2009 147 158
83. R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, and V.P. Sukhatme First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
84. A.C. Staff, K. Braekke, N.K. Harsem, T. Lyberg, and M.R. Holthe Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia Eur J Obstet Gynecol Reprod Biol 122 2005 33 39
85. S. Verlohren, A. Galindo, D. Schlembach, H. Zeisler, I. Herraiz, and M.G. Moertl An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia Am J Obstet Gynecol 202 2010 161.e1-11
86. S.Y. Kim, H.M. Ryu, J.H. Yang, M.Y. Kim, J.Y. Han, and J.O. Kim Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia J Korean Med Sci 22 2007 873 877
87. D.S. Torry, H.S. Wang, T.H. Wang, M.R. Caudle, and R.J. Torry Preeclampsia is associated with reduced serum levels of placenta growth factor Am J Obstet Gynecol 179 1998 1539 1544
88. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177 182
89. A. Reuvekamp, F.V. Velsing-Aarts, I.E. Poulina, J.J. Capello, and A.J. Duits Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia Br J Obstet Gynaecol 106 1999 1019 1022
90. J.C. Livingston, R. Chin, B. Haddad, E.T. McKinney, R. Ahokas, and B.M. Sibai Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia Am J Obstet Gynecol 183 2000 1554 1557
91. J.C. Livingston, B. Haddad, L.A. Gorski, P. Neblett, R.A. Ahokas, and R. Ramsey Placenta growth factor is not an early marker for the development of severe preeclampsia Am J Obstet Gynecol 184 2001 1218 1220
92. M.L. Tjoa, J.M. van Vugt, M.A. Mulders, R.B. Schutgens, C.B. Oudejans, and I.J. van Wijk Plasma placenta growth factor levels in midtrimester pregnancies Obstet Gynecol 98 2001 600 607
93. R.J. Levine, R. Thadhani, C. Qian, C. Lam, K.H. Lim, and K.F. Yu Urinary placental growth factor and risk of preeclampsia JAMA 293 2005 77 85
94. O. Lapaire, A. Shennan, and H. Stepan The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application Eur J Obstet Gynecol Reprod Biol 151 2010 122 129
95. J.P. Kusanovic, R. Romero, T. Chaiworapongsa, O. Erez, P. Mittal, and E. Vaisbuch A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 2009 1021 1038
96. F. Crispi, E. Llurba, C. Dominguez, P. Martin-Gallan, L. Cabero, and E. Gratacos Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction Ultrasound Obstet Gynecol 31 2008 303 309
97. A.E. Diab, M.M. El-Behery, M.A. Ebrahiem, and A.E. Shehata Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry Int J Gynaecol Obstet 102 2008 146 151
98. J. Espinoza, R. Romero, J.K. Nien, R. Gomez, J.P. Kusanovic, and L.F. Goncalves Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor Am J Obstet Gynecol 196 2007 326.e1-13
99. H. Stepan, A. Geipel, F. Schwarz, T. Kramer, N. Wessel, and R. Faber Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion Am J Obstet Gynecol 198 2008 175.e1-6
100. H. Stepan, A. Unversucht, N. Wessel, and R. Faber Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion Hypertension 49 2007 818 824
101. I.A. Buhimschi, G. Zhao, E.F. Funai, N. Harris, I.E. Sasson, and I.M. Bernstein Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia Am J Obstet Gynecol 199 2008 551.e1-16